KEGG   Camelus bactrianus (Bactrian camel): 105064166
Entry
105064166         CDS       T07534                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
cbai  Camelus bactrianus (Bactrian camel)
Pathway
cbai01522  Endocrine resistance
cbai01524  Platinum drug resistance
cbai04012  ErbB signaling pathway
cbai04066  HIF-1 signaling pathway
cbai04068  FoxO signaling pathway
cbai04110  Cell cycle
cbai04115  p53 signaling pathway
cbai04151  PI3K-Akt signaling pathway
cbai04218  Cellular senescence
cbai04630  JAK-STAT signaling pathway
cbai04921  Oxytocin signaling pathway
cbai04928  Parathyroid hormone synthesis, secretion and action
cbai04934  Cushing syndrome
cbai05160  Hepatitis C
cbai05161  Hepatitis B
cbai05163  Human cytomegalovirus infection
cbai05165  Human papillomavirus infection
cbai05166  Human T-cell leukemia virus 1 infection
cbai05167  Kaposi sarcoma-associated herpesvirus infection
cbai05169  Epstein-Barr virus infection
cbai05200  Pathways in cancer
cbai05202  Transcriptional misregulation in cancer
cbai05203  Viral carcinogenesis
cbai05205  Proteoglycans in cancer
cbai05206  MicroRNAs in cancer
cbai05210  Colorectal cancer
cbai05211  Renal cell carcinoma
cbai05212  Pancreatic cancer
cbai05213  Endometrial cancer
cbai05214  Glioma
cbai05215  Prostate cancer
cbai05216  Thyroid cancer
cbai05217  Basal cell carcinoma
cbai05218  Melanoma
cbai05219  Bladder cancer
cbai05220  Chronic myeloid leukemia
cbai05222  Small cell lung cancer
cbai05223  Non-small cell lung cancer
cbai05224  Breast cancer
cbai05225  Hepatocellular carcinoma
cbai05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:cbai00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    105064166 (CDKN1A)
   04630 JAK-STAT signaling pathway
    105064166 (CDKN1A)
   04066 HIF-1 signaling pathway
    105064166 (CDKN1A)
   04068 FoxO signaling pathway
    105064166 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    105064166 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    105064166 (CDKN1A)
   04115 p53 signaling pathway
    105064166 (CDKN1A)
   04218 Cellular senescence
    105064166 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    105064166 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    105064166 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    105064166 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    105064166 (CDKN1A)
   05206 MicroRNAs in cancer
    105064166 (CDKN1A)
   05205 Proteoglycans in cancer
    105064166 (CDKN1A)
   05203 Viral carcinogenesis
    105064166 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    105064166 (CDKN1A)
   05212 Pancreatic cancer
    105064166 (CDKN1A)
   05225 Hepatocellular carcinoma
    105064166 (CDKN1A)
   05226 Gastric cancer
    105064166 (CDKN1A)
   05214 Glioma
    105064166 (CDKN1A)
   05216 Thyroid cancer
    105064166 (CDKN1A)
   05220 Chronic myeloid leukemia
    105064166 (CDKN1A)
   05217 Basal cell carcinoma
    105064166 (CDKN1A)
   05218 Melanoma
    105064166 (CDKN1A)
   05211 Renal cell carcinoma
    105064166 (CDKN1A)
   05219 Bladder cancer
    105064166 (CDKN1A)
   05215 Prostate cancer
    105064166 (CDKN1A)
   05213 Endometrial cancer
    105064166 (CDKN1A)
   05224 Breast cancer
    105064166 (CDKN1A)
   05222 Small cell lung cancer
    105064166 (CDKN1A)
   05223 Non-small cell lung cancer
    105064166 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    105064166 (CDKN1A)
   05161 Hepatitis B
    105064166 (CDKN1A)
   05160 Hepatitis C
    105064166 (CDKN1A)
   05163 Human cytomegalovirus infection
    105064166 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    105064166 (CDKN1A)
   05169 Epstein-Barr virus infection
    105064166 (CDKN1A)
   05165 Human papillomavirus infection
    105064166 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    105064166 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    105064166 (CDKN1A)
   01522 Endocrine resistance
    105064166 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 105064166
NCBI-ProteinID: XP_010947299
UniProt: A0A9W3EGR9
LinkDB
Position
Unknown
AA seq 164 aa
MSEPSRDAHQIPRSSKACRRLFGPVDSEQLSRDCDALMASCVQEARDRWNFDFVTETPLE
GDFAWERVRGLGLPKLYLPAGPRGAWDDLGGGKRPSTSPALLQGTSQEDHVDLSLSCTLV
PRSPERPEESPGGPGTSQGRKRRQTSMTDFYHSKRRLIFSKRKP
NT seq 495 nt   +upstreamnt  +downstreamnt
atgtcggagccatccagggatgcccatcagatcccacgcagcagcaaggcgtgccgtcgc
ctcttcggcccagtggacagtgagcaactgagccgggactgtgacgcactgatggccagc
tgtgtgcaggaggcccgggatcgatggaacttcgactttgtcaccgagacaccgctggag
ggtgactttgcctgggagcgtgtgcggggccttggcctgcccaagctctacctgcctgca
gggccccggggggcctgggatgacctgggagggggcaagcggcccagcacctcgcctgcc
ctgctgcaggggacatctcaggaggaccacgtggacctgtcactgtcttgcacccttgtg
cctcgctcccctgagcggcctgaggagtccccaggtgggcctggcacctctcagggccga
aaacggcggcagaccagcatgacagatttctatcactccaaacgccggctgatcttctcc
aagaggaagccctaa

DBGET integrated database retrieval system